 |
|
 |
| |
 |
|
Class Information
Number: 514/177
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Cyclopentanohydrophenanthrene ring system doai > Oxygen double bonded to a ring carbon of the cyclopentanohydrophenanthrene ring system
Description: Subject matter wherein a nuclear carbon of the cyclopentanohydrophenanthrene nucleus is bonded to an oxygen atom through a double bond (C=O).
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 5792757 |
19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
Aug. 11, 1998 |
| 5789442 |
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents |
Aug. 4, 1998 |
| 5783571 |
Method of altering hypothalamic function by nasal administration of estrene steroids |
Jul. 21, 1998 |
| 5773431 |
Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent |
Jun. 30, 1998 |
| 5770227 |
Progesterone replacement therapy |
Jun. 23, 1998 |
| 5767113 |
Compounds useful for concurrently activating glucocorticoid-induced response and reducing multidrug resistance |
Jun. 16, 1998 |
| 5763430 |
Method of treating a viral infection by administering a steroid compound |
Jun. 9, 1998 |
| 5763431 |
Method for regulating neuropeptide hormone secretion |
Jun. 9, 1998 |
| 5763433 |
Pharmaceutical compositions containing 3-beta-hydroxylated 6,7-substituted steroid derivatives, and use thereof |
Jun. 9, 1998 |
| 5756482 |
Method of attenuation of nervous system damage |
May. 26, 1998 |
| 5753639 |
Low dose androgenic compounds for prevention and treatment of endometriosis |
May. 19, 1998 |
| 5744463 |
Treatment of side effects of progestins and progesterone analogues used for birth control |
Apr. 28, 1998 |
| 5744462 |
Steroids useful as anti-cancer and anti-obesity agents |
Apr. 28, 1998 |
| 5741787 |
Antiglucocorticoid steroids for the treatment of anxiety disorders |
Apr. 21, 1998 |
| 5739125 |
11 Beta-aryl-gona-4, 9-dien-3-ones |
Apr. 14, 1998 |
| 5733902 |
Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors |
Mar. 31, 1998 |
| 5723455 |
Antiandrogenic agents and related pharmaceutical compositions and methods of use |
Mar. 3, 1998 |
| 5721226 |
Method for inhibiting angiogenesis using squalamine and squalamine steroid derivatives |
Feb. 24, 1998 |
| 5714481 |
Derivatives of 5-androsten-17 ones and 5-androstan-17-ones |
Feb. 3, 1998 |
| 5710143 |
Anti-obesity agents |
Jan. 20, 1998 |
| 5707983 |
Treatment of alzheimer's disease and modulation of immune system with .DELTA.5-androstenes |
Jan. 13, 1998 |
| 5703066 |
Progestationally active 19,11-bridged 4-estrenes |
Dec. 30, 1997 |
| 5700794 |
Treatment of ocular hypotony |
Dec. 23, 1997 |
| 5700793 |
Steroids useful as anti-cancer and anti-obesity agents |
Dec. 23, 1997 |
| 5696106 |
Steroids useful as anti-cancer and anti-obesity agents |
Dec. 9, 1997 |
| 5686437 |
Estrogen nucleus derivatives for use in the inhibition of sex steroid activity |
Nov. 11, 1997 |
| 5677292 |
Derivatives of estra 1,3,5(10)triene-17-one,3-amino compounds and their use |
Oct. 14, 1997 |
| 5670495 |
Method of pretreating an animal with a corticosteroid prior to infusion of a perfluorochemical emulsion |
Sep. 23, 1997 |
| 5665390 |
Stabilized tablet formulation |
Sep. 9, 1997 |
| 5661143 |
Estrogenic compounds as anti-mitotic agents |
Aug. 26, 1997 |
| 5661141 |
19-oxygenated steroids as therapeutic agents |
Aug. 26, 1997 |
| 5656294 |
Colonic delivery of drugs |
Aug. 12, 1997 |
| 5656613 |
Treatment of hyperandrogenic conditions |
Aug. 12, 1997 |
| 5656621 |
Steroids useful as anti-cancer and anti-obesity agents |
Aug. 12, 1997 |
| 5646136 |
Methods of inhibiting angiogenesis and tumor growth, and treating ophthalmologic conditions with angiostatic and therapeutic steroids |
Jul. 8, 1997 |
| 5643604 |
Parenteral dosage form |
Jul. 1, 1997 |
| 5639743 |
Compositions and methods for treating exocrine gland atrophy |
Jun. 17, 1997 |
| 5637310 |
Method of treating prostatic adenocarcinoma |
Jun. 10, 1997 |
| 5635197 |
Treatment and prevention of prostatic cancer metastasis |
Jun. 3, 1997 |
| 5633011 |
Progesterone replacement therapy |
May. 27, 1997 |
| RE35517 |
Method, compositions, and compounds for modulating brain excitability |
May. 20, 1997 |
| 5631247 |
Compounds and compositions with nitrogen-containing non-basic side chains |
May. 20, 1997 |
| 5629007 |
Method of preventing prostatic cancer development |
May. 13, 1997 |
| 5629295 |
Steroidal glycosides for treating hypercholesterolemia |
May. 13, 1997 |
| 5629303 |
Controlled release systems and low dose androgens |
May. 13, 1997 |
| 5622944 |
Testosterone prodrugs for improved drug delivery |
Apr. 22, 1997 |
| 5622942 |
Percutaneous absorptive anesthetic |
Apr. 22, 1997 |
| 5620705 |
Progestin tablet |
Apr. 15, 1997 |
| 5616573 |
Glucocorticoids |
Apr. 1, 1997 |
| 5610150 |
Method of treatment of androgen-related diseases |
Mar. 11, 1997 |
|
|
|
 |
|
 |
|
| |
Randomly Featured Patents |
|
